Trial Profile
Open Label Trial of Aripiprazole in the Treatment of CD in Adolescents.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2017
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Conduct disorder
- Focus Therapeutic Use
- 19 Jan 2010 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 19 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2009 New trial record